Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mindfulness may boost hope and coping in gynecological cancer patients

NCT ID NCT07497802

Symptom relief Sponsor: Ondokuz Mayıs University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an 8-week online mindfulness program can improve hope, emotional coping, quality of life, and psychological well-being in women with gynecological cancer. About 96 women currently receiving treatment will be randomly assigned to either the mindfulness program or usual care. The program includes breathing exercises, body scans, and guided imagery done in small groups via video calls.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mindfulness-Based Psychoeducation Program
What this could lead to
If it works, this program could offer a practical, at-home way to help women with gynecological cancer feel more hopeful and cope better emotionally.
What could go wrong
This is a small, early-stage trial (96 participants) testing a behavioral intervention, not a drug. Results may not apply to all patients, and benefits may be modest or not last long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 96 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Aug 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women who voluntarily agree to participate in the study * Women aged 18 years and older * Women diagnosed with gynecological cancer and currently undergoing active treatment (e.g., surgery, chemotherapy, radiotherapy, immunotherapy, or targeted therapy) * Ability to participate in online sessions from home after hospital discharge * Ability to use a smartphone or similar device to access online sessions * Having at least basic literacy (able to read and write) * Expected life expectancy ≥ 12 months, as evaluated by the responsible oncologist Exclusion Criteria: * Diagnosis of a psychiatric disorder that may interfere with participation * Current use of psychiatric medications * Previous participation in Mindfulness-Based Stress Reduction (MBSR) or similar mindfulness programs * Having a physical condition that prevents participation in the intervention sessions * Presence of communication barriers (e.g., inability to speak Turkish, severe hearing impairment) * Having a history of previous cancer diagnosis or metastatic disease * Participants who voluntarily withdraw from the study during the intervention period * Participation in less than 80% of the intervention sessions (attendance at fewer than 6 out of 8 sessions) * Discontinuation of treatment or death during the study period

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gynecologic cancers are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

female reproductive organ cancer Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gynecologic cancers

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ondokuz Mayis University Health Practice and Research Center

    Samsun, 55139, Turkey (Türkiye)

  • Samsun City Hospital

    Samsun, 55139, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.